Precigen, Inc. (PGEN)
4.47
+0.25
(+5.92%)
USD |
NASDAQ |
Nov 06, 16:00
4.47
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash from Investing (Quarterly) : -13.97M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -13.97M |
| June 30, 2026 | 26.69M |
| March 31, 2026 | 20.97M |
| December 31, 2025 | 39.87M |
| September 30, 2025 | -63.39M |
| June 30, 2025 | 28.44M |
| March 31, 2025 | -6.457M |
| December 31, 2024 | -65.37M |
| September 30, 2024 | 5.653M |
| June 30, 2024 | 14.96M |
| March 31, 2024 | 24.04M |
| December 31, 2023 | 13.29M |
| September 30, 2023 | 10.52M |
| June 30, 2023 | 23.50M |
| March 31, 2023 | -50.41M |
| December 31, 2022 | 11.42M |
| September 30, 2022 | 181.86M |
| June 30, 2022 | 16.57M |
| March 31, 2022 | 16.57M |
| December 31, 2021 | 15.93M |
| September 30, 2021 | 22.01M |
| June 30, 2021 | 16.62M |
| March 31, 2021 | -129.10M |
| December 31, 2020 | 40.18M |
| September 30, 2020 | 0.181M |
| Date | Value |
|---|---|
| June 30, 2020 | 23.97M |
| March 31, 2020 | -36.55M |
| December 31, 2019 | 54.51M |
| September 30, 2019 | 13.78M |
| June 30, 2019 | -15.03M |
| March 31, 2019 | 33.59M |
| December 31, 2018 | 30.74M |
| September 30, 2018 | -161.03M |
| June 30, 2018 | -13.46M |
| March 31, 2018 | -7.456M |
| December 31, 2017 | 23.91M |
| September 30, 2017 | 28.14M |
| June 30, 2017 | 17.73M |
| March 31, 2017 | 33.64M |
| December 31, 2016 | 16.75M |
| September 30, 2016 | -63.77M |
| June 30, 2016 | 14.74M |
| March 31, 2016 | 3.88M |
| December 31, 2015 | -3.493M |
| September 30, 2015 | -239.51M |
| June 30, 2015 | 8.225M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | 10.46M |
| September 30, 2014 | -39.75M |
| June 30, 2014 | -22.60M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.28M |
| Aldeyra Therapeutics, Inc. | -0.0231M |
| Repligen Corp. | 63.99M |
| AC Immune SA | -- |
| Inovio Pharmaceuticals, Inc. | 6.147M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 11.88M |
| Cash from Financing (Quarterly) | 0.733M |
| Free Cash Flow | -74.32M |
| Free Cash Flow Per Share (Quarterly) | 0.0272 |
| Free Cash Flow to Equity (Quarterly) | 11.19M |
| Free Cash Flow to Firm (Quarterly) | 14.43M |
| Free Cash Flow Yield | -4.31% |